Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Lignende værker

• Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.
  af: van Engelen, B G, et al.
  Udgivet: (1994)
• Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
  af: Stangel, M., et al.
  Udgivet: (2000)
• Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
  af: Bus, S. R. M., et al.
  Udgivet: (2021)
• MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
  af: Tourbah, Ayman, et al.
  Udgivet: (2016)
• Intravenous immunoglobulins for the treatment of mild to moderate Alzheimer’s disease: a phase II, randomised, double-blind, placebo-controlled dose-finding trial
  af: Dodel, Richard, et al.
  Udgivet: (2013)